Seasonal allergic rhinitis (hay fever) is caused by an immune response to allergens such as pollen. Symptoms can include sneezing, nasal congestion, itching, and watery eyes. While many people experience mild symptoms, some individuals may have more persistent or severe symptoms that impact daily activities.

For most patients, first-line treatments include antihistamines, nasal corticosteroid sprays, and other therapies available over the counter or via a GP.

These options are generally recommended before considering other interventions.

In selected cases where symptoms are severe and have not responded adequately to standard treatments, an injectable prescription medicine may be considered following assessment by a qualified prescriber. One such option is triamcinolone acetonide, a corticosteroid that works by reducing inflammation associated with the allergic response.

Triamcinolone acetonide injection is a prescription-only medicine. Its use for hay fever is not routinely recommended and may be considered off-label; suitability must be determined on an individual basis after clinical evaluation.

The treatment may provide symptom relief for some patients for a period of time; however, responses can vary and it does not cure the underlying condition.

As with all medicines, there are potential risks and side effects. These may include local reactions at the injection site (such as skin thinning or changes in skin appearance), as well as systemic effects associated with corticosteroids. Because the medication is long-acting, any side effects may persist for several weeks.

This treatment is not suitable for everyone. A full consultation is required to assess your medical history, discuss alternative options, and review the potential benefits and risks. Written information will be provided to support informed decision-making before any treatment is offered.

 

A Consultation fee is £90